Concepedia

Sylvie Froidevaux

SF

Statistics

Publications

24

Citations

1.2K

H-Index

15

Active since

1991

Affiliations

University Children’s Hospital Basel(Current)

University Hospital of Basel

Université de Strasbourg

Idorsia (Switzerland)

Sylvie Froidevaux is an author at University Children’s Hospital Basel specializing in pharmacology, medicine, and oncology.

Publications per year

1991–2024

24

Publications

24

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy

A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke et al. · Chemistry - A European Journal · 1999 · 334 citations · Full text

, , +17

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.

Sylvie Froidevaux, Martine Calame‐Christe, Jochen Schuhmacher et al. · PubMed · 2004 · 136 citations

, , +17

The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation

Luca Piali, Sylvie Froidevaux, Patrick Hess et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 107 citations

, , +15

Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model

Sylvie Froidevaux, Alex N. Eberlé, Martine Christe et al. · International Journal of Cancer · 2002 · 92 citations

, , +17

Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.

Sylvie Froidevaux, Martine Calame‐Christe, Heidi Tanner et al. · PubMed · 2005 · 77 citations

, , +17

1–5 of 24